BioCore
BioCore's Overview
BIOCORE Co., Ltd. is a full-service Contract Research Organization (CRO) headquartered in South Korea, specializing in providing comprehensive clinical research solutions to the pharmaceutical, biotechnology, and medical device industries. With a commitment to quality, scientific integrity, and client satisfaction, BIOCORE supports all phases of clinical development, from early phase trials to post-marketing surveillance. Their services include clinical operations, data management, biostatistics, regulatory affairs, and medical writing, aiming to accelerate the delivery of innovative therapies to patients globally.
Where is BioCore's Headquarters?
HQ Function
Serves as the central hub for global operations, strategic planning, R&D oversight, and corporate governance for all BIOCORE Co., Ltd. activities.
Notable Features:
Modern office facilities within a major business district in Seoul, equipped with advanced technology infrastructure for research support, data management, and global communication.
Work Culture:
A dynamic and collaborative environment focused on scientific excellence, innovation in clinical research, and a strong commitment to ethical practices and regulatory compliance. Emphasis on teamwork, continuous learning, and professional development for its specialized staff.
HQ Significance:
The Seoul headquarters is pivotal for BIOCORE's access to the burgeoning Asia-Pacific (APAC) biotech market, its strong local talent pool of researchers and medical professionals, and its strategic partnerships within South Korea's advanced healthcare ecosystem.
Values Reflected in HQ: The headquarters' operations and professional environment reflect BIOCORE's core values of quality, integrity, client-centricity, scientific rigor, and a commitment to advancing healthcare through reliable clinical research.
Location:
BIOCORE Co., Ltd. supports global clinical trials through its strategically located offices and operational capabilities spanning South Korea (HQ), the USA, Australia, China, and Germany. This international network enables them to effectively manage multi-regional studies, provide localized regulatory expertise, ensure data quality, and offer comprehensive clinical research services—including trial management, biostatistics, data management, and site monitoring—across key pharmaceutical development markets worldwide.
Street Address:
12F, Building A, 25, Beobwon-ro 11-gil
City:
Seoul
State/Province:
Seoul
Country:
Republic of Korea
BioCore's Global Presence
Newark, DE/USA
Address: BIOCORE USA Inc., 200 Continental Drive, Suite 401, Newark, DE 19713, USA
To provide localized support, project management, and regulatory expertise for BIOCORE's clinical research services in the United States and expand its presence in the significant North American market.
Sydney, NSW/Australia
Address: BIOCORE Australia Pty Ltd., Level 17, 9 Castlereagh Street, Sydney NSW 2000, Australia
Facilitates access to Australia's established clinical trial infrastructure, diverse patient populations, and streamlined regulatory pathways, supporting global drug development programs.
Shanghai/China
Address: Biocore China (Shanghai) Co., Ltd., Room 605, Building 8, Lane 168, Linhong Road, Changning District, Shanghai, China
To capitalize on the rapidly growing Chinese pharmaceutical market, provide localized CRO services, and support clinical trials conducted within China for global and local sponsors.
Frankfurt am Main/Germany
Address: BIOCORE Europe GmbH, Theodor-Heuss-Allee 112, 60486 Frankfurt am Main, Germany
To provide comprehensive CRO services and strategic access to the European market, leveraging Germany's strong pharmaceutical industry and facilitating multi-national European clinical trials.
Buying Intent Signals for BioCore
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of BioCore
As of April 2025, BioCore' leadership includes:
Investors of BioCore
BioCore has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
No high-profile C-suite executive hires or exits at BIOCORE Co., Ltd. have been widely reported in major English-language financial news outlets or readily available public disclosures over the past 12 months. Key personnel changes are typically disclosed in Korean regulatory filings (e.g., DART) or specialized local business media, which may not always receive broad international coverage.
Technology (Tech Stack) used by BioCore
Discover the tools BioCore uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
BioCore Email Formats and Examples
BIOCORE Co., Ltd. likely utilizes standard corporate email formats, typically combining employee names or initials with their official domain, such as 'biocorecro.com' or potentially 'biocore.co.kr' for some communications. Common patterns include [first_initial][last] or [first].[last].
Likely formats: [first_initial][last]@biocorecro.com (e.g., jsmith@biocorecro.com) or [first].[last]@biocorecro.com (e.g., jane.smith@biocorecro.com). The exact primary format is not publicly confirmed.
Format
ychoi@biocorecro.com (This is a speculative example for CEO Young-Kyo Choi based on common formats)
Example
75%
Success rate
News and media
The Bell Korea • October 12, 2023
BIOCORE Co., Ltd. Announces Third-Party Allotment Paid-in Capital Increase
BIOCORE Co., Ltd. announced a resolution by its board of directors for a paid-in capital increase through third-party allotment. The purpose was to raise approximately KRW 5 billion for operational funding and to strengthen the company's financial structure....more
KIND (Korea Investors' Network for Disclosure System) / Company Disclosure • March 29, 2024
BIOCORE Co., Ltd. Holds 17th Annual General Meeting of Shareholders
BIOCORE Co., Ltd. convened its 17th regular annual general meeting of shareholders on March 29, 2024. Key agenda items included the approval of financial statements for the fiscal year 2023, appointment of directors, approval of director remuneration limits, and appointment of an auditor....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including BioCore, are just a search away.